<DOC>
	<DOCNO>NCT01291069</DOCNO>
	<brief_summary>This pilot study aim assess short-term effect Tadalafil hemodynamic response exercise exercise capacity patient Fontan circulation . Data regard effect size drug tolerability use design randomize multicenter trial . The long-term goal investigation systematically evaluate effect tadalafil therapy exercise performance , quality life , delay functional deterioration patient single ventricle physiology .</brief_summary>
	<brief_title>Effect Tadalafil Exercise Capacity Pediatric Fontan Patients</brief_title>
	<detailed_description />
	<mesh_term>Tadalafil</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Patients undergone Fontan procedure ( regardless type Fontan connection presence absence fenestration ) Age 8.0 35.0 year Stable clinical condition last 3 month ( i.e . No change medication , treatment , development new symptom ) Ability perform exercise test Consent assent ( appropriate participate study receive information concerning procedure , risk , possible clinical benefit ) Patients enrol without regard gender , race , ethnicity . All patient meet study eligibility approach consent . Severe heart failure ( New York Heart Association functional class III IV ) Presence liver renal dysfunction base late lab test result Presence hear visual deficit Transcutaneous arterial blood oxygen saturation ( SaO2 ) &lt; 80 % rest History echocardiographic , MRI , angiographic evidence Fontan pathway obstruction History exerciseinduced lifethreatening arrhythmia unstable rhythm ( i.e . atrial flutter ) Known suspect pregnancy . Females reproductive age group screen pregnancy use serum beta hCG prior administer study drug . Patients open label sildenafil tadalafil</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Fontan</keyword>
	<keyword>Tadalafil</keyword>
	<keyword>Exercise performance</keyword>
</DOC>